
GRDN Stock Forecast & Price Target
GRDN Analyst Ratings
Bulls say
Guardian Pharmacy Service is a leading provider in the fragmented long-term care pharmacy industry, with robust technology assets and strong financial flexibility. Its local leadership model and focus on customer service/relationships drive organic growth, while M&A and greenfield expansion opportunities provide potential for further growth. The company's recent vaccine outperformance and solid financials also support a positive outlook.
Bears say
Guardian Pharmacy Service is a financially stable company with a robust M&A pipeline and clean balance sheet. However, the company's focus on organic growth and disciplined M&A strategy may hinder its ability to fully capitalize on potential opportunities, including acquiring assets from Omnicare. Additionally, the company's strong cash flow and financial flexibility could support continued investment and growth. While we have adjusted our estimates and raised our price target, our negative outlook is due to concerns about potential missed opportunities and limited potential for short-term stock growth.
This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.
GRDN Analyst Forecast & Price Prediction
Start investing in GRDN
Order type
Buy in
Order amount
Est. shares
0 shares